التفاصيل البيبلوغرافية
العنوان: |
2325P Selinexor (XPO1 inhibitor) in combination with tepotinib (MET inhibitor) potentially inhibits SHOC2 and KRAS G12C in KRAS G12C mutant non-small cell lung cancer |
المؤلفون: |
Rosell, R., Jain, A., Codony-Servat, J., Shivamallu, C., Kollur, S.P., Prasad, A., Vishwanath, P., Jantus Lewintre, E., Ito, M., Cardona Zorrilla, A.F., Arrieta Rodriguez, O.G., Pedraz-Valdunciel, C., González Nieto, J., Aguilar, A., Molina-Vila, M.A., Gonzalez Cao, M. |
المصدر: |
In Annals of Oncology October 2023 34 Supplement 2:S1188-S1188 |
قاعدة البيانات: |
ScienceDirect |